Neue Daten zu AJOVY® (Fremanezumab) zur Migräneprävention stellen Behandlungspausen in Frage

View Full Size 

Download

• Full Size JPEG, 2161x776, 220.6 KB
• Small JPEG, 480x172, 53.0 KB
• Preview JPEG, 144x52, 26.9 KB
• Thumbnail JPEG, 120x43, 24.6 KB